Skip to main content

Spectrum: Autism Research News

Tag: clinical trials

January 2022

Growth factor analogue shows promise for Rett syndrome in late-stage trial

by  /  25 January 2022

Girls and young women with Rett syndrome have less severe anxiety and breathing problems after treatment with trofinetide, an analogue of insulin-like growth factor 1, according to an unpublished placebo-controlled trial.

Comments
Colorful illustration shows pills, bottles and blister packs falling all around.

Spectrum’s Autism Drug Trial Tracker, an interactive tool to explore clinical trial data

by  /  12 January 2022

Spectrum’s Autism Drug Trial Tracker provides interactive, curated information about hundreds of clinical trials for autism and related conditions.

Comments

Autism Drug Trial Tracker

by  /  12 January 2022

Explore hundreds of clinical trials with our interactive tool.

Comments

Autism Drug Trial Tracker: User Guide

by  /  12 January 2022

Learn how to use the Autism Drug Trial Tracker, with specific examples and detailed explanations for each data column.

Comments

The connection between oxytocin and autism, explained

by  /  6 January 2022

Oxytocin, cemented in the popular imagination as the “love molecule,” could serve as a treatment for some autistic people who naturally have low levels of the hormone, researchers say.

Comments
December 2021

First-of-its-kind commission defines ‘profound autism,’ issues recommendations

by  /  6 December 2021

Use of the term ‘profound autism’ is among the recommendations made by a panel of autism researchers, clinicians, autistic adults and parents of autistic people.

Comments
Gloved hands holding bag of placental cord blood containing stem cells.

‘Pay-to-participate’ autism stem-cells paper retracted

by  /  2 December 2021

One family paid more than $7,000 for their child to participate in a small clinical trial in Panama. The trial’s lead author did not disclose that detail.

Comments
November 2021
Dr. Shafali Jeste portrait with a vibrant fuschia background.

Shafali Jeste: Early autism meets its match

by  /  30 November 2021

Shafali Jeste has spent the bulk of her scientific career searching for biological markers of autism. Her goal: to improve lives through early diagnosis and speedy testing of therapies.

Comments
Professor Andrew Whitehouse surrounded by playful children in the busy clinic in Subiaco Western Australia.

Beyond the bench: A conversation with Andrew Whitehouse

by  /  24 November 2021

Andrew Whitehouse talks about his conservation efforts in the Australian Outback, what it’s like to be an identical twin and why he leaves work promptly at 5 p.m.

Comments
Illustration of a network of blue neurons overlaid with marijuana leaves.

Special report: How cannabis could shape future autism therapies

by  /  8 November 2021

Cannabis-derived drugs are approved to treat only a small number of autism-related conditions, but many autistic people and their families experiment with medical marijuana to ease autism traits. In this special report, Spectrum rounds up what the science says about cannabis and autism.

Comments